TUDOR INVESTMENT CORP ET AL - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$218,021
-53.9%
363,4900.0%0.00%
-66.7%
Q2 2023$472,537
+73733.9%
363,4900.0%0.01%
-40.0%
Q1 2023$640
-45.7%
363,490
-3.1%
0.01%
-56.5%
Q4 2022$1,178
-99.2%
375,138
+1100.2%
0.02%
+666.7%
Q3 2022$153,000
-74.4%
31,256
-78.3%
0.00%
-81.2%
Q2 2022$597,000
+130.5%
144,315
+223.7%
0.02%
+166.7%
Q1 2022$259,000
-78.7%
44,579
-72.5%
0.01%
-70.0%
Q4 2021$1,214,000
+65.8%
161,841
+99.1%
0.02%
+66.7%
Q3 2021$732,000
-18.2%
81,282
-14.1%
0.01%
-69.2%
Q3 2020$895,000
+47.9%
94,667
+40.1%
0.04%
+30.0%
Q2 2020$605,000
+255.9%
67,573
+356.0%
0.03%
+900.0%
Q4 2018$170,000
-81.1%
14,819
-73.0%
0.00%
-87.0%
Q4 2017$900,000
+93.5%
54,864
+76.9%
0.02%
+91.7%
Q3 2017$465,000
+99.6%
31,009
+17.0%
0.01%
+71.4%
Q2 2017$233,000
+15.9%
26,507
-59.7%
0.01%
+40.0%
Q4 2016$201,000
-24.4%
65,800
+275.8%
0.01%
-44.4%
Q4 2014$266,000
+86.0%
17,511
+28.8%
0.01%
+50.0%
Q3 2013$143,000
+6.7%
13,600
-20.9%
0.01%
-40.0%
Q2 2013$134,00017,2000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders